Role of MP-HBEGF-EGFR signaling for inflammatory action of oxidized phospholipids
Role of MP-HBEGF-EGFR signaling for inflammatory action of oxidized phospholipids
批准号:
8898181
负责人:
Sangderk Lee
金额:
$24.1万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2011
资助国家:
美国
项目状态:
已结题
起止时间:
2011-08-01 至 2016-07-31
关键词:
Animal ModelAreaAtherosclerosisBindingBlood VesselsCCL2 geneCardiovascular DiseasesCell surfaceCellsCellular biologyCholesterolChronicCysteineData SetDevelopmentDiseaseEducational BackgroundEndothelial CellsEndotheliumEpidermal Growth Factor ReceptorEventGene ExpressionGenerationsGenesGeneticGenetic PolymorphismGenotypeGoalsHistocytochemistryHumanIL8 geneIn VitroInfiltrationInflammationInflammatoryInflammatory ResponseKineticsKnockout MiceLearningLesionLife ExpectancyLipidsMediatingMembrane MicrodomainsMentorsMetalloproteasesMethodsModificationMusOxidative StressPathway AnalysisPathway interactionsPharmacologyPhasePhospholipidsPopulationPostdoctoral FellowPredispositionPreventivePublic HealthReagentReceptor ActivationReceptor SignalingResearchResearch PersonnelRoleSignal PathwaySignal TransductionStructureSystemTestingTrainingTranscriptUniversitiesVariantVascular Endothelial CellVascular EndotheliumVascular SystemWeightWorkabstractingagedanalytical toolcareercytokineexperiencegenetic approachheparin-binding EGF-like growth factorin vivomacrophagemeetingsmouse modelnoveloxidationoxidized phosphatidyl cholineresearch facilityresponsesuccesstherapeutic targettoolvalidation studiesvascular inflammation
中文摘要
项目总结/文摘:
英文摘要
Project Summary/Abstract:
This K99/R00 will support candidate's career goal to become a researcher in the area of cardiovascular
disease with a focus on atherosclerosis. The candidate has past educational background related with cell
biology and pharmacology mainly on receptor signaling projects, and simple array analysis. The candidate is
currently a postdoctoral fellow at UCLA and the K99 training will be executed under mentor Dr. Judith A.
Berliner and co-mentor Dr. Aldons J. Lusis at UCLA. The university system is well equipped with highly
productive and supportive research facilities including systemized training of conduct of research. The
university administrative system is very supportive for the success of new investigators. Dr. Berliner is a
pioneering researcher who identified important roles of oxidized phospholipids in the vascular inflammatory
responses. Her experience with analysis of immuno-histochemistry will be important to the success of the
proposed studies. Dr. Lusis is an outstanding researcher in the field of systems genetics whose work has been
important in identifying genetic factors and novel signaling pathways controlling the development of
atherosclerosis. During this K99 training phase, the candidate will meet frequently with mentor and co-mentor.
The candidate will also meet with advisory board committee every 6 months. During the K99 mentoring phase,
the candidate will focus on mastering immuno-histochemistry and lesion analysis methods, which is one of big
advantages of current lab and associated Core labs. Another important aspect of the K99 will be learning the
analytical tools to do analyze high-throughput transcript and genotyping datasets; these studies are being
performed by a large number of those in the Lusis group. During the independent R00 phase, the candidate
will mainly focus on the in-depth mechanistic studies for MP activation by Ox-PAPC in the endothelial cells,
and the validation study of the significance of the genetic factors and cellular pathways identified via systems
genetics approach. The main goal of this proposed study is to define proximal events in oxidized phospholipid
(Ox-PAPC) activation of this inflammatory pathway. In this study in Aim 1, candidate will identify the
mechanism by which Ox-PAPC induces activation of the MPs using in vitro culture of endothelial cells. In Aim
2, candidate will determine if this pathway is activated for inflammation and lesion formation in mouse model of
atherosclerosis. Finally, in Aim 3, a systems genetics approach will be used to identify genetic factors and
novel pathways controlling proximal inflammatory responses in vascular endothelium. For this study the
candidate will use transcript and genotyping data sets of the aortic endothelial cells isolated from 96 human
donors which datasets and cells are currently available. The K99 training phase under mentor and co-mentor
in the current lab clearly fill the technical gaps to execute the projects proposed. After the training phase, the
candidate will be equipped with more diverse tools and approaches to study the cardiovascular disease for
successful transit to the independent R00 phase.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of MP-HBEGF-EGFR signaling for inflammatory action of oxidized phospholipids
-
批准号:8296587
-
项目类别:
-
资助金额:$9.0万
-
财政年份:2011
-
负责人:Sangderk Lee
-
依托单位:
Role of MP-HBEGF-EGFR signaling for inflammatory action of oxidized phospholipids
-
批准号:8189619
-
项目类别:
-
资助金额:$9.0万
-
财政年份:2011
-
负责人:Sangderk Lee
-
依托单位:
Role of MP-HBEGF-EGFR signaling for inflammatory action of oxidized phospholipids
-
批准号:8699257
-
项目类别:
-
资助金额:$24.01万
-
财政年份:2011
-
负责人:Sangderk Lee
-
依托单位:
Role of MP-HBEGF-EGFR signaling for inflammatory action of oxidized phospholipids
-
批准号:8659637
-
项目类别:
-
资助金额:$23.7万
-
财政年份:2011
-
负责人:Sangderk Lee
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: